Roberts Capital Advisors LLC Invests $1.08 Million in CME Group Inc. $CME

Key Points

• Roberts Capital Advisors LLC has purchased a new stake in CME Group Inc., acquiring 4,080 shares valued at approximately $1,082,000, which now constitutes about 0.9% of its investment portfolio.
• CME Group recently reported earnings of $2.96 per share, surpassing expectations, with revenues of $1.69 billion for the quarter, marking a year-over-year increase of 10.4%.
• The company announced a quarterly dividend of $1.25 per share, reflecting an annualized dividend yield of 1.8%, with a payout ratio of 48.40%.

Roberts Capital Advisors LLC acquired a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the first quarter, according to its most recent filing with the SEC. The fund acquired 4,080 shares of the financial services provider's stock, valued at approximately $1,082,000. CME Group accounts for approximately 0.9% of Roberts Capital Advisors LLC's investment portfolio, making the stock its 25th biggest holding.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. SeaCrest Wealth Management LLC increased its stake in CME Group by 3.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock worth $366,000 after acquiring an additional 40 shares during the last quarter. OneAscent Financial Services LLC increased its stake in CME Group by 4.0% in the 1st quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock worth $293,000 after acquiring an additional 43 shares during the last quarter. Ballentine Partners LLC increased its stake in CME Group by 0.8% in the 1st quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock worth $1,546,000 after acquiring an additional 45 shares during the last quarter. Wealthcare Advisory Partners LLC increased its stake in CME Group by 3.6% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock worth $356,000 after acquiring an additional 47 shares during the last quarter. Finally, Koshinski Asset Management Inc. increased its stake in CME Group by 1.4% in the 1st quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock worth $934,000 after acquiring an additional 48 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Charles P. Carey sold 500 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the completion of the transaction, the director owned 4,900 shares of the company's stock, valued at approximately $1,300,215. This represents a 9.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William R. Shepard bought 256 shares of the firm's stock in a transaction dated Wednesday, June 25th. The stock was purchased at an average cost of $270.53 per share, with a total value of $69,255.68. Following the transaction, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 1,390 shares of company stock worth $382,110. Corporate insiders own 0.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CME shares. Morgan Stanley upped their target price on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research note on Thursday, April 24th. Oppenheimer upped their price objective on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Barclays set a $298.00 price objective on CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. UBS Group reiterated a "neutral" rating and issued a $305.00 price objective on shares of CME Group in a report on Thursday, July 24th. Finally, Piper Sandler upped their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat, CME Group presently has a consensus rating of "Hold" and an average target price of $261.93.

CME Group Trading Down 1.3%

NASDAQ CME traded down $3.51 on Monday, hitting $270.41. The company's stock had a trading volume of 2,164,956 shares, compared to its average volume of 2,079,104. CME Group Inc. has a 52-week low of $206.44 and a 52-week high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company's 50-day simple moving average is $275.56 and its 200 day simple moving average is $267.83. The firm has a market cap of $97.45 billion, a P/E ratio of 26.18, a PEG ratio of 4.86 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The business had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same quarter last year, the business posted $2.56 EPS. The business's revenue was up 10.4% on a year-over-year basis. Research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a $1.25 dividend. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group's dividend payout ratio (DPR) is 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.